PAAS vs. CRMD
PAAS (Pan American Silver Corp.) and CRMD (CorMedix Inc.) are both stocks. PAAS operates in Silver (Basic Materials), while CRMD operates in Biotechnology (Healthcare). Over the past 10 years, PAAS returned 14.08%/yr vs -1.91%/yr for CRMD. At a 0.07 correlation, their price movements are largely independent.
Performance
PAAS vs. CRMD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PAAS achieves a -6.53% return, which is significantly higher than CRMD's -24.85% return. Over the past 10 years, PAAS has outperformed CRMD with an annualized return of 14.08%, while CRMD has yielded a comparatively lower -1.91% annualized return.
PAAS
- 1D
- 3.46%
- 1M
- -24.13%
- YTD
- -6.53%
- 6M
- -2.63%
- 1Y
- 68.49%
- 3Y*
- 50.01%
- 5Y*
- 11.06%
- 10Y*
- 14.08%
CRMD
- 1D
- -2.46%
- 1M
- 16.53%
- YTD
- -24.85%
- 6M
- -23.93%
- 1Y
- -41.18%
- 3Y*
- 15.11%
- 5Y*
- 1.21%
- 10Y*
- -1.91%
PAAS vs. CRMD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PAAS Pan American Silver Corp. | -6.53% | 160.40% | 26.61% | 2.50% | -33.00% | -26.78% | 46.88% | 63.86% | -5.30% | 3.86% |
CRMD CorMedix Inc. | -24.85% | 43.58% | 115.43% | -10.90% | -7.25% | -38.76% | 2.06% | 12.87% | 158.00% | -67.32% |
Correlation
The correlation between PAAS and CRMD is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since May 13, 2010 | 0.07 |
The correlation between PAAS and CRMD shifts across timeframes, from 0.07 (all time) to 0.18 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
PAAS:
$20.31B
CRMD:
$812.69M
PAAS:
$3.21
CRMD:
$2.10
PAAS:
14.98
CRMD:
4.16
PAAS:
4.75
CRMD:
1.88
PAAS:
2.76
CRMD:
1.86
PAAS:
$4.02B
CRMD:
$400.05M
PAAS:
$1.76B
CRMD:
$343.39M
PAAS:
$2.14B
CRMD:
$207.97M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PAAS vs. CRMD — Risk / Return Rank
PAAS
CRMD
PAAS vs. CRMD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pan American Silver Corp. (PAAS) and CorMedix Inc. (CRMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PAAS | CRMD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.85 | ||
| Sortino ratioReturn per unit of downside risk | +2.32 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 0.92 | +0.32 |
| Calmar ratioReturn relative to maximum drawdown | 1.95 | -0.66 | +2.61 |
| Martin ratioReturn relative to average drawdown | 5.44 | -0.97 | +6.41 |
Loading charts...
Drawdowns
PAAS vs. CRMD - Drawdown Comparison
The maximum PAAS drawdown since its inception was -85.10%, smaller than the maximum CRMD drawdown of -98.28%. Use the drawdown chart below to compare losses from any high point for PAAS and CRMD.
Loading charts...
Drawdown Indicators
| PAAS | CRMD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.10% | -98.28% | +13.18% |
Max Drawdown (1Y)Largest decline over 1 year | -35.33% | -62.26% | +26.93% |
Max Drawdown (3Y)Largest decline over 3 years | -35.33% | -62.26% | +26.93% |
Max Drawdown (5Y)Largest decline over 5 years | -58.89% | -66.91% | +8.02% |
Max Drawdown (10Y)Largest decline over 10 years | -66.74% | -94.77% | +28.03% |
Current DrawdownCurrent decline from peak | -29.51% | -82.29% | +52.78% |
Average DrawdownAverage peak-to-trough decline | -41.64% | -77.55% | +35.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.63% | 42.56% | -29.93% |
Volatility
PAAS vs. CRMD - Volatility Comparison
Pan American Silver Corp. (PAAS) has a higher volatility of 18.82% compared to CorMedix Inc. (CRMD) at 12.12%. This indicates that PAAS's price experiences larger fluctuations and is considered to be riskier than CRMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PAAS | CRMD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.82% | 12.12% | +6.70% |
Volatility (6M)Calculated over the trailing 6-month period | 44.62% | 51.58% | -6.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 55.23% | 68.31% | -13.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.97% | 77.11% | -29.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.62% | 91.70% | -42.08% |
Dividends
PAAS vs. CRMD - Dividend Comparison
PAAS's dividend yield for the trailing twelve months is around 1.29%, while CRMD has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRMD CorMedix Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PAAS Pan American Silver Corp. | 1.29% | 0.89% | 1.98% | 2.45% | 2.75% | 1.36% | 0.64% | 0.59% | 0.96% | 0.64% | 0.33% | 4.23% |
Financials
PAAS vs. CRMD - Financials Comparison
This section allows you to compare key financial metrics between Pan American Silver Corp. and CorMedix Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PAAS vs. CRMD - Profitability Comparison
PAAS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pan American Silver Corp. reported a gross profit of 608.00M and revenue of 1.15B. Therefore, the gross margin over that period was 52.7%.
CRMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a gross profit of 105.12M and revenue of 127.43M. Therefore, the gross margin over that period was 82.5%.
PAAS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pan American Silver Corp. reported an operating income of 560.00M and revenue of 1.15B, resulting in an operating margin of 48.5%.
CRMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported an operating income of 63.66M and revenue of 127.43M, resulting in an operating margin of 50.0%.
PAAS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pan American Silver Corp. reported a net income of 457.00M and revenue of 1.15B, resulting in a net margin of 39.6%.
CRMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a net income of 38.60M and revenue of 127.43M, resulting in a net margin of 30.3%.
Frequently Asked Questions
PAAS and CRMD have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PAAS has higher volatility (18.82%) compared to CRMD (12.12%). In terms of maximum drawdown, PAAS dropped -85.10% vs CRMD's -98.28%.
PAAS currently has the higher Sharpe Ratio (1.25 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PAAS and CRMD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer